Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8815917
DP2 antagonist and uses thereof
granted -
US 8816002
Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
granted -
US 8815927
Bivalent diazo bicyclic Smac mimetics and the uses thereof
granted -
US 8815830
Nucleosides with antiviral and anticancer activity
granted -
US 8815845
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
granted -
US 8815848
Compositions and methods for inhibition of the JAK pathway
granted -
US 8816071
Tocotrienol derivatives and associated methods
granted -
US 8816077
Oligomer-protein tyrosine kinase inhibitor conjugates
granted -
US 8816088
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
granted -
US 8815907
Quaternary ammonium compounds useful as muscarinic receptor antagonists
granted -
US 8815801
Controlled release composition and method of producing the same
granted -
US 8816085
Methylpyrrolopyridinecarboxamides
granted -
US 8816046
Compositions and methods for CaMKII inhibitors and uses thereof
granted -
US 8815558
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
granted -
US 8815246
Fc receptor binding proteins
granted -
US 8815240
Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
granted -
US 8815511
Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
granted -
US 8815227
Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
granted -
US 8815226
Protein-polymer-drug conjugates
granted -
US 8815866
Aminopyridine kinase inhibitors
granted -
US 8815885
Methods and compositions for modulating IRE1, SRC, and ABL activity
granted -
US 8815229
Granulysin in immunotherapy
granted -
US 8809502
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
granted -
US 8809364
Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.